For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…
XYZ-research offers a comprehensive analysis of key market trends in the global Oral Contrast Agent market. It also includes discussion on historical trends, current market status, competitive landscape, growth opportunities and challenges which are backed by factful feedbacks.
Global markets continue to sink as the coronavirus spreads, reaching over 200 countries in total by the end of March. Now the outbreak continued to grow, as the number of cases in USA, Italy, Spain, Germany, France all spiked, Europe and USA have now become the epicenter of the outbreak, Cases in China appear have steadied in April, but there's growing concern about the overall impact to the global market.
In China market, which experienced a difficult 2019 due to slowing domestic consumption and the impact of the Sino-US trade war, is once again facing more disruption and uncertainty at the hands of the coronavirus pandemic. Sales and consumption all fell in the first quarter of 2020, compared with the same period in 2019. The sales revenue of the major players will likely continue slowing in the 2nd quarter but in the second half of the year the fiscal and monetary policy would likely cause a strong rebound
In order to stop the spread of the COVID-19 outbreak, countries and world capital have been put under strict lockdown, bringing a total halt to major industrial production chains. It has caused supply chain disruptions for nearly three-quarters of U.S. companies, and in the second quarter, domestically consumption is likely to be hit even harder. The same situation also appeared in Europe, as the epidemic has required large-scale restrictions on the movement of people, investment, consumption and exports will all be strongly impacted by the epidemic, domestic production and consumption will plummet in the first half of 2020. We expected a U-shaped recovery in the second half of the year in USA and Europe market.
Brazil is already the hardest hit country in South America, many of these nations are still in the early stages of the virus's proliferation. Infection levels have not yet peaked in April. South America 's market were on shaky ground even before the devastating impacts of the coronavirus, following a synchronized economic slowdown last year. China's market downturn is impacting its trading partners in this region.
China, Japan, South Korea, India, and other Asia countries took the lead in introducing unprecedented measures to contain the virus, the market confidence in Asia-Pacific region is returning, EU and USA have relaxed its fiscal rules with maximum flexibility, this will stimulate the market demand in the second half of 2020.
Due to delays in the transport of components and raw materials, along with quarantine restrictions, the transportation of raw materials is affected, this will cause tight supply, and then the price of raw materials to rise. Meanwhile, as end-user demand weakens, many players are also facing the risk of higher inventory backlog, which may lead to passive production reduction, some traditional retailers began to develop the online business.
This report extensively provides a quantitative analysis of the industry from 2014-2026 based on the current international situation, by Region, Type, Application. Consumption assessment by application, production by type in different regions. Furthermore, the report quantifies the market share held by the major players of the industry and provides an in-depth view of the competitive landscape. The market size in terms of revenue (USD) and production is calculated for the study period along with the details of the factors affecting the market growth (drivers and restraints). The worldwide market for Oral Contrast Agentmarket will reach xxx Million USD in 2020 and is expected to grow at a CAGR of xx% 2021-2026.
Geographically, global Oral Contrast Agent market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including
- GE Healthcare (US)
- Bracco Imaging (Italy)
- Bayer HealthCare (Germany)
- Guerbet (France)
- Lantheus (US)
- Daiichi Sankyo (Japan)
- Unijules Life Sciences (India)
- J.B. Chemicals and Pharmaceuticals (India)
- Spago Nanomedicine (Sweden)
- Taejoon Pharm (South Korea)
- Jodas (India)
- Magnus Health (India)
On the basis of product, we research the production, revenue, price, market share and growth rate, primarily split into
- Barium-based Contrast Media
- Iodinated Contrast Media
- Gadolinium-based Contrast Media
- Microbubble Contrast Media
For the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate of Oral Contrast Agent for each application, including
- Cardiovascular Disorders
- Cancer
- Gastrointestinal Disorders
- Musculoskeletal Disorders
- Neurological Disorders
- Nephrological Disorders
Production, consumption, revenue, market share and growth rate are the key targets for Oral Contrast Agent from 2014 to 2026 (forecast) in these regions
- China
- USA
- Europe
- Japan
- Korea
- India
- Southeast Asia
- South America
If you have any special requirements, please let us know and we will offer you the report as you want.